. 2021 Oct 13;50(3):273–276. doi: 10.1016/j.ajic.2021.10.003

Table 1.

Summary of 10 fully vaccinated veterans hospitalized with COVID-19

Patient number	Age (y)	Body Mass Index (kg/m²)	Medical comorbidities	Immune system suppression	Presenting symptoms	Vaccine series received	Days between second vaccine dose and hospitalization	COVID-19 laboratory testing					Peak supp oxygen need (L/min)	Peak hospital level of care	Status at hospital discharge
								PCR^§ status (C_t)	Antigen status^║	Anti-S IgM^¶ (nl, 0-0.99)	Anti-N IgG^¶ (nl, 0-1.39)	Results interpretation
1^*	78	33	CHF, cirrhosis, CKD	N	Dyspnea, LE swelling	Pfizer	66	Positive (22.4)	Negative	0.53	0.67	Acute infection	4	General	Living
2^*	71	32	CHF, COPD, DM, IPF	Y^‡	Dyspnea, LE swelling	Pfizer	63	Positive (–)	Positive	0.13	0.11	Acute infection	Mech Vent	ICU	Deceased
3^*	91	32	Afib, HTN, CVA, AI	N	Cough, N/V/D	Pfizer	60	Positive (13.1)	Positive	0.26	0.03	Acute infection	6	General	Living
4^*	80	18	CHF, Dementia, CVA	N	Weakness, lethargy	Pfizer	54	Positive (34.7)	Negative	0.19	0.03	Acute infection	-	General	Living
5^*	88	41	COPD, OSA, DM	N	Dyspnea, cough	Moderna	63	Positive (13.6)	Positive	0.14	0.03	Acute infection	2	General	Living
6	82	19	COPD, ESRD on HD, HTN	N	Dyspnea, weakness	Moderna	21	Positive (32.3)	Negative	5.79	6.23	Resolving/ Resolved infection	-	ICU	Living
7^*^,^†	73	26	CAD, HTN,	N	Fever, bacterial endocarditis	Pfizer	38	Positive (37.3)	Negative	0.87	3.55	Resolving/ Resolved infection	-	General	Living
8	88	33	CAD, DM, CKD	N	Axillary abscess	Moderna	50	Positive (44.5)	Negative	2.62	2.20	Resolving/ Resolved infection	-	General	Living
9^*	83	32	COPD, DM, CKD	N	COVID-19 positive on SNF testing	Pfizer	42	Positive (–)	Positive	0.28	0.52	Acute infection	-	General	Living
10^*	78	45	CHF, COPD, DM, CKD	N	Dyspnea, fever	Pfizer	40	Positive (19.2)	Positive	0.94	0.02	Acute infection	2	General	Living

Afib, Atrial fibrillation; AI, Aortic insufficiency; CHF, Congestive heart failure; CKD, Chronic kidney disease; COPD, Chronic obstructive pulmonary disease; C_t, Cycle threshold (if known); CVA, Cerebrovascular accident; DM, Diabetes mellitus; ESRD on HD, End-stage renal disease on hemodialysis; HTN, Hypertension; ICU, intensive care unit; IPF, Idiopathic pulmonary fibrosis; LE, lower extremity; Mech Vent, mechanical ventilation; nl, normal limit; N/V/D, nausea, vomiting, diarrhea; OSA, Obstructive sleep apnea; SNF, skilled nursing facility.

^⁎

Considered vaccination failure.

^†

Transferred from another acute care hospital.

^‡

Receiving nintedanib therapy.

^§

PCR assay (Cepheid, Sunnyvale, CA, bioMerieux. Marcy-l'Étoile, France).

^║

SARS-CoV-2 antigen test (BD Biosciences San Jose, CA).

^¶

Serology Anti-S IgM and Anti-N IgG (Abbott Laboratories, Lake Forest, IL).